Patent US5208236A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5208236A Expired / Lapsed US ⏱️ 0.0 years remaining

N-(acylaminomethyl)glutaryl amino acids and use

Assignee: Merck Sharp & Dohme LLC
•
Filing: 1992-09-23
•
Granted: 1993-05-04
•
Expires: 2012-09-23
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Novel glutarylamino acid derivative dual inhibitors of neutral endopeptidase and angiotensin converting enzyme of the formula ##STR1## wherein: R 1 and R 3 are independently hydroxy, lower alkoxy, aryllower alkoxy, amino, lower alkylamino and di-(lower alkyl)amino; R 2 is H or hydroxy; R 4 is aryl, substituted aryl, heteroaryl or substituted heteroaryl; R 6 is H or R 7 --(CH 2 ) 3 --, wherein R 7 is amino or (aryllower alkoxy)carbonylamino; Q is --C(O)-- or --SO 2 --; Y is lower alkyl, lower alkoxy, aryllower alkoxy, amino, lower alkylamino, di-(lower alkyl)amino, or a group of the formula ##STR2## wherein A is a bond, --N(R 5 )--, or --O--; and R 5 is H or lower alkyl; B is H or Z--(CH 2 ) m -- Z is amino, lower alkylamino, di-(lower alkyl)amino, (aryllower alkoxy)carbonylamino, 1-pyrrolidino or 1-piperidino; m=1,2,3,4 or 5; and n=1,2 or 3; or or a pharmaceutically acceptable addition salt thereof; useful in the treatment of cardiovascular disorders, are disclosed.

Inventors

  • 👤 Bernard R. Neustadt

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-05 20:13
CPC Classifications
C; C07; C07D; C07D295/00; C07D295/16; C07D295/20; C07D295/215; C07C; C07C237/00; C07C237/24; C07C271/00; C07C271/06; C07C271/08; C07C271/10; C07C271/22; C07C275/00; C07C275/04; C07C275/06; C07C275/14; C07C307/00; C07C307/04; C07C307/06; C07C311/00; C07C311/01; C07C311/02; C07C311/03; C07C311/05; C07C2601/00; C07C2601/06; C07C2601/08

Claims Analysis

Total Claims: 12
Claim 1
Independent Claim 158 words
A compound having the structural formula ##STR41## wherein: R 1 and R 3 are independently selected from the group consisting of hydroxy, lower alkoxy, aryllower alkoxy, amino, lower alkylamino and di-(lower alkyl)amino; R 2 is H or hydroxy; R 4 is aryl, substituted aryl, heteroaryl or substituted heteroaryl; R 6 is H or R 7 --(CH 2 ) 3 --, wherein R 7 is amino or (aryllower alkoxy)carbonylamino; Q is --C(O)-- or --SO 2 --; Y is lower alkyl, lower alkoxy, aryllower alkoxy, amino, lower alkylamino, di-(lower alkyl)amino, or a group of the formula ##STR42## wherein A is a bond, --N(R 5 )--, or --O--; p and r are independently 2 or 3; and wherein R 5 is H or lower alkyl; B is H or Z--(CH 2 ) m -- Z is amino, lower alkylamino, di-(lower alkyl)amino, (aryllower alkoxy)carbonylamino, (lower alkoxy)carbonylamino ##STR43## m=1,2,3,4 or 5; and n=1,2 or 3; or or a pharmaceutically acceptable addition salt thereof.
Claim 2
Dependent Claim 158 words
A compound having the structural formula ##STR41## wherein: R 1 and R 3 are independently selected from the group consisting of hydroxy, lower alkoxy, aryllower alkoxy, amino, lower alkylamino and di-(lower alkyl)amino; R 2 is H or hydroxy; R 4 is aryl, substituted aryl, heteroaryl or substituted heteroaryl; R 6 is H or R 7 --(CH 2 ) 3 --, wherein R 7 is amino or (aryllower alkoxy)carbonylamino; Q is --C(O)-- or --SO 2 --; Y is lower alkyl, lower alkoxy, aryllower alkoxy, amino, lower alkylamino, di-(lower alkyl)amino, or a group of the formula ##STR42## wherein A is a bond, --N(R 5 )--, or --O--; p and r are independently 2 or 3; and wherein R 5 is H or lower alkyl; B is H or Z--(CH 2 ) m -- Z is amino, lower alkylamino, di-(lower alkyl)amino, (aryllower alkoxy)carbonylamino, (lower alkoxy)carbonylamino ##STR43## m=1,2,3,4 or 5; and n=1,2 or 3; or or a pharmaceutically acceptable addition salt thereof.
Claim 3
Dependent Claim 25 words
A compound of claim 1 wherein R 1 and R 3 are hydroxy, R 2 is H, and R 4 is aryl or substituted aryl.
Claim 4
Dependent Claim 12 words
A compound of claim 2 wherein n=2 and R 4 is 4-hydroxyphenyl.
Claim 5
Dependent Claim 23 words
A compound of claim 3 having the structural formula ##STR44## wherein B, Y, Q and R 6 are as defined in claim 1.
Claim 6
Dependent Claim 20 words
A compound of claim 4 wherein B is Z--(CH 2 ) m --, and Z is amino or (aryllower alkoxy)carbonylamino.
Claim 7
Dependent Claim 24 words
A compound of claim 5 wherein R 6 is H, and Y is lower alkoxy, di-(lower alkyl)amino or a group of the formula ##STR45##
Claim 8
Dependent Claim 25 words
A compound of claim 4 wherein B is H, Q is --SO 2 --, and R 6 is R 7 --(CH 2 ) 3 --.
Claim 9
Dependent Claim 10 words
A compound of claim 7 wherein Y is lower alkyl.
Claim 10
Dependent Claim 80 words
A compound of claim 1 having the structural formula __________________________________________________________________________ ##STR46## wherein Compound B R.sup.6 Q Y __________________________________________________________________________ 1 CbzNH(CH.sub.2).sub.4 H C(O) CH.sub.3 O 2 NH.sub.2 (CH.sub.2).sub.4 H C(O) CH.sub.3 O 1A CbzNH(CH.sub.2).sub.4 H C(O) (CH.sub.3).sub.2 NH 2A NH.sub.2 (CH.sub.2).sub.4 H C(O) (CH.sub.3).sub.2 NH 1B CbzNH(CH.sub.2).sub.4 H C(O) ##STR47## 2B NH.sub.2 (CH.sub.2).sub.4 H C(O) ##STR48## 1C CbzNH(CH.sub.2).sub.4 H SO.sub.2 (CH.sub.3).sub.2 NH 2C NH.sub.2 (CH.sub.2).sub.4 H SO.sub.2 (CH.sub.3).sub.2 NH 1D H NH.sub.2 (CH.sub.2).sub.3 SO.sub.2 CH.sub.3 2D H CbzNH(CH.sub.2).sub.3 SO.sub.2 CH.sub.3 __________________________________________________________________________
Claim 11
Dependent Claim 28 words
A pharmaceutical composition useful for treating hypertension, congestive heart failure or renal insufficiency comprising an effective amount of a compound of claim 1 in a pharmaceutically acceptable carrier.
Claim 12
Dependent Claim 27 words
A method of treating hypertension, congestive heart failure or renal insufficiency comprising administering to a mammal in need of such treatment a pharmaceutical composition of claim 10.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1996-05-03 1996-11-02 1997-05-04 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2000-05-03 2000-11-02 2001-05-04 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2004-05-03 2004-11-02 2005-05-04 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag